RESUMEN
PURPOSE: Cladophialophora bantiana is a wonted melanized fungus causing brain abscess. In past many cases were reported from Asia, particularly from India. Of late, there is a rise in cases in places besides Asia and hence a review of the cases is warranted. METHODS: We present a case of fatal cerebral phaeohyphomycosis caused by C. bantiana and conduct a systematic review of culture confirmed brain abscess due to C. bantiana reported between 2015 and 2022. RESULTS: Of the 39 cases found, majority (68%) were immunocompromised. The various clinical presentations were headache (53%), hemiparesis (34%), visual disturbance (25%), altered sensorium (18%), aphasia/dysarthria (12%) and seizures (9%). Isolated lesion was observed in 18 (60%) patients. In the sequence of occurrence, the lesions were in frontal (30%), temporal (27%) and parietal (20%) region. There were five cases with coinfections such as concurrent detection of Nocardia pneumonia in two cases, toxoplasma DNA in brain abscess, coexisting pulmonary Cryptococcus neoformans infection and coexisting Candida in a case of brain abscess in one case each. Surgical intervention was performed in 84% cases. Antifungal therapy included voriconazole (80%), liposomal amphotericin B (76%), 5-fluorocytosine (30%), posaconazole (10%), and amphotericin B deoxycholate (6%). The overall mortality was 50% with lower mortality (42%) in regions outside Asia compared to Asia (63.6%) though not statistically significant. CONCLUSIONS: C. bantiana brain abscess is an emerging infection worldwide. Next generation sequencing is an upcoming promising diagnostic test. Early complete excision of the lesion with effective antifungals may improve the outcome.
Asunto(s)
Ascomicetos , Absceso Encefálico , Feohifomicosis Cerebral , Humanos , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/tratamiento farmacológico , Feohifomicosis Cerebral/microbiología , Antifúngicos/uso terapéutico , Voriconazol/uso terapéutico , Absceso Encefálico/diagnóstico , Absceso Encefálico/tratamiento farmacológico , Absceso Encefálico/microbiologíaRESUMEN
Central nervous system (CNS) phaeohyphomycosis is a rare and often fatal fungal infection. Our study reported a case series of eight CNS phaeohyphomycosis cases at our institution over the past 20 years. We did not observe the common pattern of risk factors, abscess location, or number of abscesses among them. Most patients were immunocompetent without classic risk factors for fungal infection. Early diagnosis and aggressive management with surgical intervention and prolonged antifungal therapy can lead to a favorable outcome. The study highlights the need for further research to better understand the pathogenesis and optimal management of this challenging rare infection.
Asunto(s)
Feohifomicosis Cerebral , Micosis , Feohifomicosis , Animales , Feohifomicosis/diagnóstico , Feohifomicosis/tratamiento farmacológico , Feohifomicosis/microbiología , Feohifomicosis/veterinaria , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/tratamiento farmacológico , Feohifomicosis Cerebral/veterinaria , Micosis/tratamiento farmacológico , Micosis/veterinaria , Factores de Riesgo , Antifúngicos/uso terapéuticoRESUMEN
Cerebral phaeohyphomycosis is frequently a fatal disease caused by truly neurotropic dematiaceous fungi. Although rare, this infection occurs especially among immunocompetent patients, and the clinical symptoms are often misdiagnosed as a cerebral tumour or bacterial brain abscess. The appropriate diagnosis and therapy of cerebral infections by melanized fungi are very challenging if they are caused by mysterious fungi with unknown ecological niche. We reported the second case of cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Iran and the first culture-confirmed case. In this report, the differential diagnosis and histopathological findings are discussed and a review of the literature is provided.
Asunto(s)
Ascomicetos/aislamiento & purificación , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/patología , Anciano , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Diagnóstico Diferencial , Femenino , Histocitoquímica , Humanos , Irán , Imagen por Resonancia Magnética , Técnicas Microbiológicas , MicroscopíaRESUMEN
The Fonsecaea species, which are the leading causes of chromoblastomycosis, are not considered neurotropic fungal agents. Fonsecaea pedrosoi is the primary species in the genus and is usually isolated from chromoblastomycosis cases. However, the recently distinguished species F. monophora has been reported in a few cerebral phaeohyphomycosis cases. Here, a case of cerebral phaeohyphomycosis caused by Fonsecaea monophora is presented in a 71-year-old female subject with chronic diabetes mellitus and hypertension. The identification of F. monophora was made through mycological and molecular analysis, and an isolate was differentiated from the closely related F. pedrosoi by sequence data on key bases on the ribosomal internal transcribed spacer region. The case was successfully treated with surgical and medical approaches, and the patient has remained healthy and stable after a ten-month follow up. Given the increasing incidence of this type of infection of the central nervous system (CNS), this case provides further support for the consideration that F. monophora might represent a neurotropic agent.
Asunto(s)
Ascomicetos/genética , Ascomicetos/aislamiento & purificación , Feohifomicosis Cerebral/microbiología , Hongos Mitospóricos/genética , Hongos Mitospóricos/aislamiento & purificación , Anciano , Ascomicetos/ultraestructura , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/tratamiento farmacológico , ADN de Hongos/genética , ADN Espaciador Ribosómico/genética , Complicaciones de la Diabetes , Femenino , Humanos , Hipertensión/complicaciones , Técnicas de Tipificación Micológica , Filogenia , Análisis de Secuencia de ADNRESUMEN
Phaeohyphomycosis is a term used to define infections caused by darkly pigmented fungi with septate hyphae which contain melanin in their cell walls. Although fungi rarely cause central nervous system (CNS) infections, the incidence of CNS infections caused by melanin-containing fungi has been increasing in the recent years. Cladophialophora bantiana is the most frequently isolated species from cerebral phaeohyphomycosis. It mostly affects adult men in the second and third decade of life and about half of the cases occurs in immunocompetent patients. In this report, the isolation of C.bantiana from brain tissue of an immunocompetent patient who was operated with the initial diagnosis of a brain abscess, was presented. A 27 year-old male patient presenting without any chronic disease was admitted to the emergency department of our hospital with the complaints of persistent headache and diplopia. Magnetic resonance imaging (MRI) showed a space-occupying lesion in the right parietal lobe and left frontal lobe. Brain abscess was diagnosed in the patient who was referred to the neurosurgery department. Treatment was initiated with ceftriaxone and metronidazole. The abscess material sent for direct microscopic examination in the mycology laboratory was stained with Gram and Giemsa and cultured in the Sabouraud dextrose agar medium (SDA) with and without antibiotics (cycloheximide and chloramphenicol). Then, it was incubated at 37°C and 25°C. Direct examination and staining revealed a septate hyphae. The patient who received liposomal amphotericin B was referred to the infectious diseases department. Surface colors of all media including SDA with cycloheximide were olive-gray to black and contained velvety colonies. Lemon-like very long and integrated chains of conidium with poor branching in cornmeal Tween 80 agar, as well as growth at 42°C in passages, positive urease test result and cycloheximide resistance suggested C.bantiana. The isolate was confirmed as C. bantiana based on its DNA sequence analysis. Minimum inhibitor concentration (MIC) values for amphotericin B, voriconazole, caspofungin, and posaconazole were 2 µg/ml, 0.03 µg/ml, 0.03 µg/ml and 0.03 µg/ml, respectively. Liposomal amphotericin B was replaced with voriconazole due to the antifungal susceptibility profile. The patient who was symptom-free was discharged at 24 days after hospitalization with oral voriconazole treatment. In conclusion, cerebral phaeohyphomycosis should be considered in immunocompetent individuals. Given the fact that early diagnosis saves lives, such specimens should promptly be sent for mycological analysis.
Asunto(s)
Antifúngicos/uso terapéutico , Ascomicetos/aislamiento & purificación , Absceso Encefálico/tratamiento farmacológico , Infecciones Fúngicas del Sistema Nervioso Central/tratamiento farmacológico , Feohifomicosis Cerebral/tratamiento farmacológico , Pirimidinas/uso terapéutico , Triazoles/uso terapéutico , Adulto , Antifúngicos/farmacología , Ascomicetos/clasificación , Ascomicetos/efectos de los fármacos , Absceso Encefálico/diagnóstico , Absceso Encefálico/microbiología , Infecciones Fúngicas del Sistema Nervioso Central/diagnóstico , Infecciones Fúngicas del Sistema Nervioso Central/microbiología , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/microbiología , Lóbulo Frontal , Humanos , Inmunocompetencia , Imagen por Resonancia Magnética , Masculino , Lóbulo Parietal , Pirimidinas/farmacología , Triazoles/farmacología , VoriconazolRESUMEN
Cerebral phaeohyphomycosis (CP) stands as an exceedingly uncommon yet severe type of fungal infection affecting the central nervous system, attributable to dematiaceous fungi. Despite the patient's immune status, CP is associated with grave prognosis. In the present study, authors describe the first case of left thalamic fungal abscess due to Rhinocladiella mackenziei in an immunocompetent 39-year-old male patient in Jaipur, Rajasthan. Early diagnosis by direct microscopy of aspirated pus and extensive management with surgical excision and prolonged antifungal coverage showed favourable outcome. The present case is one of the few cases documented globally who has survived.
Asunto(s)
Antifúngicos , Absceso Encefálico , Humanos , Masculino , Adulto , Absceso Encefálico/microbiología , Absceso Encefálico/diagnóstico , Absceso Encefálico/tratamiento farmacológico , Antifúngicos/uso terapéutico , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/microbiología , India , Tálamo/patología , Tálamo/microbiología , Tálamo/diagnóstico por imagen , Resultado del TratamientoRESUMEN
Cerebral mycosis is a significant cause of morbidity among immunocompromised populations. We present here a case of cerebral infection with Scedosporium apiospermum and Phaeoacremonium parasiticum in a 49-year-old renal transplant recipient. Fourteen years after renal transplantation, the patient presented with invasive pulmonary aspergillosis treated with intravenous liposomal amphotericin B. The patient had clinical and radiographic improvement. However, 6 weeks later, the patient presented with cerebral infection. Magnetic resonance imaging revealed multiple rim enhancing brain abscesses. Brain and cerebrospinal fluid cultures ultimately grew Scedosporium apiospermum and Phaeoacremonium parasiticum. The patient was treated with voriconazole for 6 months and had clinical and radiologic improvement. We believe this is the first reported case of co-infection of the brain with scedosporiosis and phaeohyphomycosis in a renal transplant recipient, who had received intravenous liposomal amphotericin B. Voriconazole may represent a new therapeutic option for these simultaneous infections in the brain.
Asunto(s)
Absceso Encefálico/microbiología , Coinfección/microbiología , Huésped Inmunocomprometido , Micosis/diagnóstico , Antifúngicos/uso terapéutico , Absceso Encefálico/diagnóstico , Absceso Encefálico/tratamiento farmacológico , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/tratamiento farmacológico , Coinfección/diagnóstico , Coinfección/tratamiento farmacológico , Humanos , Trasplante de Riñón , Masculino , Persona de Mediana Edad , Micosis/tratamiento farmacológico , Pirimidinas/uso terapéutico , Scedosporium , Triazoles/uso terapéutico , VoriconazolRESUMEN
INTRODUCTION: Cladophialophora bantiana is a filamentous fungus, known as a dematiaceous fungus because of the presence of melanin. This fungus is of clinical importance because it is neurotropic and causes cerebral phaeohyphomycosis. MATERIAL AND METHODS: The available scientific information on the development of cerebral phaeohyphomycosis caused by Cladophialophora bantiana was analysed by selecting articles from the PubMed, Scopus and Google Scholar databases that describe case reports of fungal infection by C. bantiana in adults, taking into account the analysis of the patients' symptomatology, clinical history and neuroanatomical damage, in addition to considering the mortality of the condition. RESULTS: India and United States were the countries with most case reports, with 32 and 11 cases respectively. Moreover, in terms of neuroanatomical lesions, the majority of patients suffered mixed lesions (29%) and frontal lobe lesions (22%). In accordance with the patients' condition, the pathology has a mortality rate of 62%. CONCLUSIONS: It is concluded that cerebral phaeohyphomycosis has a high mortality rate, there is no standardised treatment and, in most cases, the fungal infection of the brain is mixed and affects several different parts of it. Furthermore, if not diagnosed and treated in time, it can lead to the patients' death.
TITLE: Infección micótica por Cladophialophora bantiana y desarrollo de feohifomicosis cerebral. Revisión sistemática de 58 informes de caso.Introducción. Cladophialophora bantiana es un hongo filamentoso, denominado hongo dematiáceo por la presencia de melanina. Este hongo tiene importancia clínica por ser neurotrópico y causar feohifomicosis cerebral. Material y métodos. Se analizó la información científica disponible sobre el desarrollo de feohifomicosis cerebral provocada por Cladophialophora bantiana, seleccionando artículos de las bases de PubMed, Scopus y Google Scholar, que describen informes de caso sobre infección micótica de C. bantiana en adultos, considerando el análisis de la sintomatología, el historial clínico y los daños neuroanatómicos de los pacientes, además de considerar la mortalidad de la patología. Resultados. La India y Estados Unidos fueron los países con más informes de caso, 32 y 11 casos, respectivamente. Asimismo, en cuanto a las lesiones neuroanatómicas, en su mayoría, los pacientes sufrieron lesiones mixtas (29%) y del lóbulo frontal (22%). De acuerdo con el estado de los pacientes, la patología tiene una mortalidad del 62%. Conclusiones. Se concluye que la feohifomicosis cerebral tiene una alta mortalidad, no existe un tratamiento estandarizado y, en la mayoría de los casos, la infección fúngica del cerebro es mixta y afecta a varias partes del cerebro; además, si no se diagnostica y trata a tiempo, puede ocasionar la muerte de los pacientes.
Asunto(s)
Ascomicetos , Absceso Encefálico , Feohifomicosis Cerebral , Micosis , Adulto , Humanos , Antifúngicos/uso terapéutico , Absceso Encefálico/tratamiento farmacológico , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/tratamiento farmacológico , Micosis/tratamiento farmacológico , Informes de Casos como AsuntoRESUMEN
Cerebral phaeohyphomycosis (CP) is a rare but a highly morbid fungal infection of the central nervous system caused by the fungi belonging to the order Chaetothyriales, which includes Cladophialophora bantiana, Exophiala dermatitidis, Rhinocladiella mackenziei (RM) etc. This disease is associated with poor clinical outcomes, with reported mortality of over 80%. We present the case of a 65-year gentleman who developed CP secondary to RM infection following COVID-19 and the associated challenges in his medical and surgical management.
Asunto(s)
COVID-19 , Infecciones Fúngicas del Sistema Nervioso Central , Feohifomicosis Cerebral , Micosis , Humanos , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/tratamiento farmacológico , Feohifomicosis Cerebral/microbiología , Infecciones Fúngicas del Sistema Nervioso Central/diagnóstico , Infecciones Fúngicas del Sistema Nervioso Central/tratamiento farmacológico , Infecciones Fúngicas del Sistema Nervioso Central/microbiología , Micosis/tratamiento farmacológico , Antifúngicos/uso terapéuticoRESUMEN
Cerebral phaeohyphomycosis is a rare and frequently fatal disease. This disease is often caused by hematogenous spread of pathogens that are inoculated in the skin of the extremities after slight or minor trauma, and its mortality rate is rather high despite aggressive treatment. Our patient presented with headache and pyrexia. She was diagnosed with fungal meningitis and treated by systemic administration of voriconazole (VRCZ). However, after initial improvement, meningitis recurred. MRI of the brain showed multiple small masses in the cerebral hemisphere and she was thus referred to our Department of Neurosurgery. On admission, an examination showed that the masses were deeply located in the brain and were too small to be excised; therefore, treatment with systemic VRCZ and intrathecal amphotericin B was initially selected. However, the intracerebral masses continued to grow; therefore, they were surgically excised. Histological examination of the surgical specimens at that time identified the masses as granuloma caused by infection with Aspergillus niger. After the surgery, her general condition improved; therefore treatment with systemic and intrathecal antifungal agents were continued. However, the intracerebral masses recurred, and despite further aggressive surgical treatment and systemic and intrathecal antifungal administration, she died 43 months after the initial diagnosis. Autopsy examination showed that the cerebral lesions were phaeohyphomycotic granulomas. This paper describes the clinical presentation, histopathological results and treatment for this rare disease.
Asunto(s)
Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/cirugía , Resultado Fatal , Femenino , Humanos , Adulto JovenRESUMEN
PURPOSE: Cerebral phaeohyphomycosis is a rare and fatal fungal infection of the central nervous system (CNS) caused by dematiaceous fungi. The aim of this study was to analyse the clinico- radiological presentation, pathology and outcome of cerebral phaeohyphomycosis and discuss the relevant literature. PATIENTS AND METHODS: Data of 7 patients diagnosed with cerebral phaeohyphomycosis and managed at our institute between 2014 and 2020 was collected and reviewed retrospectively. The diagnosis was established after surgery on KOH mount, Sabouraud dextrose agar, frozen section or histopathology. The clinical, radiological and pathological characteristics along with outcomes were analysed. RESULTS: Three patients with underlying comorbidities [chronic renal failure-2 and haematological malignancy -1] presented with brain abscess. The remaining 4 had no comorbidities. Two of them mimicked cystic glioma and one patient presented as intraventricular tumour. Another patient on anti- tubercular treatment for suspected pulmonary tuberculosis presented with encephalitis. Histopathology in all patients showed diffuse micro abscesses with coarse and reactive gliosis in the adjacent brain parenchyma and chronic lymphomononuclear inflammation without angioinvasion or vasculitis. Four showed granuloma formation. Antifungals were started after diagnosis. Six out of seven patients died and one was lost to follow up. CONCLUSION: Cerebral phaeohyphomycosis presents as abscesses in immunocompromised patients and mimics tumours in immunocompetent patients. KOH mount and frozen section examination is simple yet effective tool for establishing early diagnosis. Overall, the prognosis is dismal. Administering antifungals early in the course of management along with aggressive surgical excision may improve outcomes.
Asunto(s)
Absceso Encefálico , Feohifomicosis Cerebral , Micosis , Antifúngicos/uso terapéutico , Absceso Encefálico/diagnóstico por imagen , Absceso Encefálico/cirugía , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/tratamiento farmacológico , Feohifomicosis Cerebral/microbiología , Humanos , Micosis/tratamiento farmacológico , Estudios RetrospectivosRESUMEN
Rhinocladiella mackenziei cerebral phaeohyphomycosis is a rare severe disease that has been typically described in the Middle East. Here, we report 2 cases of R. mackenziei cerebral phaeohyphomycosis in patients from Morocco, diagnosed and treated in France, and raise a concern about the ever-going extension of the area at risk for this devastating invasive fungal infection.
Asunto(s)
Ascomicetos/aislamiento & purificación , Feohifomicosis Cerebral/diagnóstico , Antifúngicos/uso terapéutico , Ascomicetos/genética , Feohifomicosis Cerebral/tratamiento farmacológico , Feohifomicosis Cerebral/cirugía , ADN de Hongos/genética , Resultado Fatal , Femenino , Humanos , Persona de Mediana Edad , MarruecosRESUMEN
We report this rare case of cerebral phaeohyphomycosis in a previously healthy Chinese boy, who was found to have caspase recruitment domain family member 9 (CARD9) deficiency. Initial radiological features suggested a neoplastic cerebral lesion, while histopathological examination supplemented by internal transcribed sequencing (ITS) of cerebral tissue confirmed the diagnosis of phaeohyphomycosis. He was treated with intravenous (IV) liposomal amphotericin B and voriconazole, guided by plasma and cerebrospinal fluid (CSF) level monitoring at drug initiation. At the 1 year follow-up, the patient demonstrated near complete neurological and radiological recovery.
Asunto(s)
Candidiasis Mucocutánea Crónica/diagnóstico , Feohifomicosis Cerebral/diagnóstico , Administración Intravenosa , Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Proteínas Adaptadoras de Señalización CARD/genética , Candidiasis Mucocutánea Crónica/tratamiento farmacológico , Feohifomicosis Cerebral/tratamiento farmacológico , Feohifomicosis Cerebral/microbiología , Feohifomicosis Cerebral/cirugía , Niño , China , Humanos , Masculino , Mutación Missense , Radiografía/métodos , Resultado del Tratamiento , Voriconazol/administración & dosificaciónRESUMEN
We report a case of cerebral phaeohyphomycosis, a fungal brain infection due to a dark (dematiaceous) fungi in a 6-year-old French Guyanese boy. The child presented fever and drowsiness due to several paraventricular brain abscesses. Neurological surgeries were performed to reduce intracranial hypertension and to obtain abscess biopsies. Mycological cultures of intraoperative samples led to the diagnosis of cerebral phaeohyphomycosis due to Cladophialophora bantiana. The patient neurological status deteriorated and remained critical after several weeks of combination antifungal therapy with voriconazole 8mg/kg/day, liposomal amphotericin B 10mg/kg/day and flucytosine 200mg/kg/day. A complete surgical resection was not possible because of multiple small abscesses. A multidisciplinary ethical staff decided on home medical care with palliative ventriculoperitoneal shunt, nasogastric feeding and analgesics. One year later, the patient's neurological condition had improved and cerebral lesions had regressed, while he had not received any antifungal treatment but only traditional medicines. Cerebral phaeohyphomycosis are rare diseases affecting immunocompromised but also apparently non-immunocompromised patients, as in this case. A complete surgical resection is not always possible and mortality rates are high in spite of treatments with a combination of antifungals. The diagnosis may be difficult because of these dematiaceous fungi's slowly growing and their potential pathogenicity for laboratory staff.
Asunto(s)
Ascomicetos/aislamiento & purificación , Infecciones Fúngicas del Sistema Nervioso Central/diagnóstico , Feohifomicosis Cerebral/diagnóstico , Antifúngicos/uso terapéutico , Ascomicetos/fisiología , Absceso Encefálico/diagnóstico , Absceso Encefálico/microbiología , Absceso Encefálico/terapia , Infecciones Fúngicas del Sistema Nervioso Central/microbiología , Infecciones Fúngicas del Sistema Nervioso Central/terapia , Feohifomicosis Cerebral/microbiología , Feohifomicosis Cerebral/terapia , Niño , Terapia Combinada , Nutrición Enteral , Guyana Francesa , Humanos , Inmunocompetencia , Intubación Gastrointestinal , Masculino , Procedimientos Neuroquirúrgicos , Derivación VentriculoperitonealAsunto(s)
Feohifomicosis Cerebral/diagnóstico , Cefalea/diagnóstico , Inmunocompetencia , Paresia/diagnóstico , Prisioneros , Prisiones , Feohifomicosis Cerebral/complicaciones , Feohifomicosis Cerebral/inmunología , Resultado Fatal , Cefalea/etiología , Cefalea/inmunología , Humanos , Inmunocompetencia/inmunología , Masculino , Paresia/etiología , Paresia/inmunología , Adulto JovenAsunto(s)
Neoplasias Encefálicas/cirugía , Feohifomicosis Cerebral/cirugía , Monitoreo Intraoperatorio , Adulto , Anfotericina B/uso terapéutico , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/tratamiento farmacológico , Neoplasias Encefálicas/patología , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/tratamiento farmacológico , Feohifomicosis Cerebral/inmunología , Humanos , Imagen por Resonancia Magnética , Masculino , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Voriconazol/uso terapéuticoAsunto(s)
Feohifomicosis , Humanos , Feohifomicosis/microbiología , Feohifomicosis/diagnóstico , Feohifomicosis/tratamiento farmacológico , Feohifomicosis/patología , Masculino , Imagen por Resonancia Magnética , Antifúngicos/uso terapéutico , Cerebelo/microbiología , Cerebelo/diagnóstico por imagen , Cerebelo/patología , Feohifomicosis Cerebral/microbiología , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/patología , Persona de Mediana EdadRESUMEN
Cladophialophora bantiana is a dematiaceous fungus with a predilection for causing central nervous system (CNS) infection manifesting as brain abscess in both immunocompetent and immunocompromised patients. In this paper, we report comprehensive genomic analyses of C. bantiana isolated from the brain abscess of an immunocompetent man, the first reported case in Malaysia and Southeast Asia. The identity of the fungus was determined using combined morphological analysis and multilocus phylogeny. The draft genome sequence of a neurotrophic fungus, C. bantiana UM 956 was generated using Illumina sequencing technology to dissect its genetic fundamental and basic biology. The assembled 37.1 Mb genome encodes 12,155 putative coding genes, of which, 1.01% are predicted transposable elements. Its genomic features support its saprophytic lifestyle, renowned for its versatility in decomposing hemicellulose and pectin components. The C. bantiana UM 956 was also found to carry some important putative genes that engaged in pathogenicity, iron uptake and homeostasis as well as adaptation to various stresses to enable the organism to survive in hostile microenvironment. This wealth of resource will further catalyse more downstream functional studies to provide better understanding on how this fungus can be a successful and persistent pathogen in human.
Asunto(s)
Ascomicetos/patogenicidad , Feohifomicosis Cerebral/diagnóstico , Feohifomicosis Cerebral/microbiología , Animales , Ascomicetos/clasificación , Ascomicetos/genética , Absceso Encefálico/microbiología , Infecciones Fúngicas del Sistema Nervioso Central/microbiología , Feohifomicosis Cerebral/metabolismo , Genoma Fúngico/genética , Genómica , Humanos , Masculino , Persona de Mediana Edad , Filogenia , Virulencia/genética , Virulencia/fisiologíaRESUMEN
Cerebral phaeohyphomycosis is a rare invasive fungal infection with very few cases referenced in the literature. There is no standardized treatment, and it is associated with poor outcomes. Cladophialophora bantiana, a fungus with special tropism for the central nervous system, is one of the causal agents of phaeohyphomycosis. The case presented here deals with a brain abscess by C. bantiana in an adult with Crohn's disease had beed being treated with immunosuppressive drugs. Despite the correct etiological diagnosis, surgical and pharmacological treatments, the patient died 32 days after surgery. A description of the case is followed by a review of all cerebral C. bantiana phaeohyphomycosis cases published in the last 10 years. Regardless of the use of advanced new imaging techniques in the diagnosis and treatment with new antifungal agents, cerebral phaeohyphomycosis by C. bantiana continues to have very poor prognosis. While new more successful therapeutic treatments appear, a combined surgical and pharmacological approach seems to be more appropriate for this severe mycosis.